Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Paulo Vidal Campregher
Affiliation
Hospital Israelita Albert Einstein
ORCID
Career Start Year
2007
Papers
51
H Index
13
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36629680
Molecular profile of patients with myelofibrosis: a 10-year experience.
Einstein (Sao Paulo)
2023
37165281
Real-world genomic profiling of acute myeloid leukemia and the impact of European LeukemiaNet risk stratification 2022 update.
Clin Transl Oncol
2023
35245845
EGFR-RAD51 fusion in lung adenocarcinoma with systemic and intracranial response to osimertinib: A case report and review of the literature.
Lung Cancer
2022
35756679
Molecular Characterization of a First-in-Human Clinical Response to Nimesulide in Acute Myeloid Leukemia.
Front Oncol
2022
36063163
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).
Genet Med
2022
35101336
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).
Genet Med
2022
32911384
Stereotyped B-cell receptors in the context of a diverse Brazilian series of chronic lymphocytic leukemia.
Blood Cells Mol Dis
2021
34036626
Severe acute respiratory syndrome coronavirus 2 and herpesvirus in oral lesions in patients with severe coronavirus disease 2019: Viral interaction?
J Dermatol
2021
33170334
Multi-center real-world comparison of the fully automated Idyllaâ¿¢ microsatellite instability assay with routine molecular methods and immunohistochemistry on formalin-fixed paraffin-embedded tissue of colorectal cancer.
Virchows Arch
2021
33423385
How I investigate minimal residual disease in acute lymphoblastic leukemia.
Int J Lab Hematol
2021
33393719
High-throughput sequencing of immunoglobulin heavy chain for minimal residual disease detection in B-lymphoblastic leukemia.
Int J Lab Hematol
2021
31628430
Prognostic impact of RAS-pathway mutations in patients with myelofibrosis.
Leukemia
2020
32535855
Genomic characterization and prognostication applied to a Brazilian cohort of patients with myelofibrosis.
Int J Hematol
2020
31286322
Autophagy inhibition potentiates ruxolitinib-induced apoptosis in JAK2<sup>V617F</sup> cells.
Invest New Drugs
2020
30785480
Pre-analytical parameters associated with unsuccessful karyotyping in myeloid neoplasm: a study of 421 samples.
Braz J Med Biol Res
2019
31373034
Distinctive IGHV gene usage and stereotyped receptors in South American patients with chronic lymphocytic leukemia.
Hematol Oncol
2019
27650062
Granulocyte whole exome sequencing and endothelial JAK2V617F in patients with JAK2V617F positive Budd-Chiari Syndrome without myeloproliferative neoplasm.
Br J Haematol
2018
30187210
Overall survival of Brazilian acute myeloid leukemia patients according to the European LeukemiaNet prognostic scoring system: a cross-sectional study.
Med Oncol
2018
30370409
ZAP-70 expression is associated with increased CD4 central memory T cells in chronic lymphocytic leukemia: cross-sectional study.
Hematol Transfus Cell Ther
2018
27903463
HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to Afatinib.
J Thorac Oncol
2017
28509585
Identification of a novel fusion TBL1XR1-PDGFRB in a patient with acute myeloid leukemia harboring the DEK-NUP214 fusion and clinical response to dasatinib.
Leuk Lymphoma
2017
28746593
Ferritin light chain gene mutations in two Brazilian families with hereditary hyperferritinemia-cataract syndrome.
Einstein (Sao Paulo)
2017
28746590
Successful treatment of post-transplant relapsed acute myeloid leukemia with FLT3 internal tandem duplication using the combination of induction chemotherapy, donor lymphocyte infusion, sorafenib and azacitidine. Report of three cases.
Einstein (Sao Paulo)
2017
28737776
Therapeutic salivary monitoring of IV busulfan in patients undergoing hematopoietic stem cell transplantation: a pilot study.
Bone Marrow Transplant
2017
26994960
Clinical features of JAK2V617F- or CALR-mutated essential thrombocythemia and primary myelofibrosis.
Blood Cells Mol Dis
2016
28074183
A Novel Assay for the Identification of NOTCH1 PEST Domain Mutations in Chronic Lymphocytic Leukemia.
Biomed Res Int
2016
27176796
Clinical response to everolimus in a patient with Hodgkin's lymphoma harboring a TSC2 mutation.
Blood Cancer J
2016
26958979
Immunophenotypic evolution of blast populations in pediatric acute myeloid leukemia.
Einstein (Sao Paulo)
2016
27036161
A novel mechanism of NPM1 cytoplasmic localization in acute myeloid leukemia: the recurrent gene fusion NPM1-HAUS1.
Haematologica
2016
25645430
Survival and graft-versus-host disease in patients receiving peripheral stem cell compared to bone marrow transplantation from HLA-matched related donor: retrospective analysis of 334 consecutive patients.
Eur J Haematol
2015
26361371
The role of magnetic resonance imaging-T2* in the evaluation of iron overload early in hereditary hemochromatosis. A cross-sectional study with 159 patients.
Am J Hematol
2015
26584717
Identification of ANLN as ETV6 partner gene in recurrent t(7;12)(p15;p13): a possible role of deregulated ANLN expression in leukemogenesis.
Mol Cancer
2015
26667746
HIGH BODY MASS INDEX AMONG PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION: RESULTS OF A CROSS-SECTIONAL EVALUATION OF NUTRITIONAL STATUS IN A PRIVATE HOSPITAL.
Nutr Hosp
2015
26193901
Eosinophil chimerism in the differential diagnosis between DEK-NUP214-positive acute myeloid leukaemia relapse and chronic graft-versus-host disease.
J Clin Pathol
2015
25658984
Comprehensive genomic profiling identifies a novel TNKS2-PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy.
Blood Cancer J
2015
24266414
Metastatic melanoma mimicking acute leukaemia.
Br J Haematol
2014
25305159
Does angiogenesis matter in primary myelofibrosis?
Rev Bras Hematol Hemoter
2014
25030673
[Not Available].
Rev Bras Hematol Hemoter
2014
24548608
Novel prognostic gene mutations identified in chronic lymphocytic leukemia and their impact on clinical practice.
Clin Lymphoma Myeloma Leuk
2014
24624038
Involvement of memory T-cells in the pathophysiology of chronic lymphocytic leukemia.
Rev Bras Hematol Hemoter
2014
23588288
Primary central nervous system lymphoma: what a neurologist/neurosurgeon should know?
Arq Neuropsiquiatr
2013
24168776
Development of plasma cell myeloma in a B-cell chronic lymphocytic leukemia patient with chromosome 12 trisomy.
BMC Res Notes
2013
23049405
Molecular biology of Philadelphia-negative myeloproliferative neoplasms.
Rev Bras Hematol Hemoter
2012
23386005
The detection of KIT mutations in acute myeloid leukemia.
Einstein (Sao Paulo)
2012
20053332
Lung function and long-term complications after allogeneic hematopoietic cell transplant.
Biol Blood Marrow Transplant
2010
20811043
Overlap and effective size of the human CD8+ T cell receptor repertoire.
Sci Transl Med
2010
20035823
Abnormalities of the alphabeta T-cell receptor repertoire in advanced myelodysplastic syndrome.
Exp Hematol
2010
19470693
Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD.
Blood
2009
19706884
Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells.
Blood
2009
19041060
Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease.
Biol Blood Marrow Transplant
2008
1 - 50 of 51
Column Actions
Search
Recommended Authors
Srinivas K Tantravahi
Huntsman Cancer Institute at the University of Utah.
Career Start Year
2012
Number of shared co-authors
1
Bartlomiej Przychodzen
Vanda Pharmaceuticals Inc.
Career Start Year
2010
Number of shared co-authors
0
Alexa J Siddon
Yale School of Medicine
Career Start Year
2010
Number of shared co-authors
2
Lina Benajiba
Universite de Paris, Inserm CIC 1427
Career Start Year
2009
Number of shared co-authors
0
Friedrich St??lzel
University Hospital TU Dresden
Career Start Year
2008
Number of shared co-authors
3
Jennifer Dunlap
Oregon Health & Science University
Career Start Year
2008
Number of shared co-authors
0
Felicitas Thol
Hannover Medical School
Career Start Year
2007
Number of shared co-authors
0
Marlise R Luskin
Dana-Farber Cancer Institute
Career Start Year
2005
Number of shared co-authors
1
Thomas Cluzeau
Universite Nice Cote d'azur, CHU de Nice
Career Start Year
2005
Number of shared co-authors
2
Jean-Baptiste Micol
INSERM U7, Universite Paris-Saclay
Career Start Year
2004
Number of shared co-authors
4
Gudrun G??hring
Hannover Medical School
Career Start Year
2002
Number of shared co-authors
0
Thomas Ernst
Universitatsklinikum Jena
Career Start Year
2002
Number of shared co-authors
0
Fei Yang
Oregon Health & Science University
Career Start Year
2002
Number of shared co-authors
1
Jeffery M Klco
St. Jude Children's Research Hospital
Career Start Year
2000
Number of shared co-authors
5
Guang Fan
Oregon Health and Science University
Career Start Year
2000
Number of shared co-authors
1
Sze Fai Yip
Tuen Mun Hospital
Career Start Year
1999
Number of shared co-authors
0
Lukas D Wartman
Washington University School of Medicine in St. Louis
Career Start Year
1998
Number of shared co-authors
8
Markus Metzler
University Hospital Erlangen
Career Start Year
1998
Number of shared co-authors
0
Bruno C Medeiros
AbbVie Inc.
Career Start Year
1996
Number of shared co-authors
2
Yongjin Li
Mayo Clinic
Career Start Year
1995
Number of shared co-authors
1
Thoralf Lange
Hospital Weissenfels
Career Start Year
1994
Number of shared co-authors
1
Seishi Ogawa
Kyoto University
Career Start Year
1993
Number of shared co-authors
1
Jean Soulier
University of Paris
Career Start Year
1993
Number of shared co-authors
1
Michael Heuser
Hannover Medical School
Career Start Year
1993
Number of shared co-authors
2
Christopher D Gocke
Johns Hopkins University School of Medicine
Career Start Year
1992
Number of shared co-authors
4
Arndt Borkhardt
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Career Start Year
1992
Number of shared co-authors
1
Jerald P Radich
Fred Hutchinson Cancer Center
Career Start Year
1989
Number of shared co-authors
5
Claude Preudhomme
Lille University Hospital, INSERM UMR-S7, CNRS UMR9020, Lille University.
Career Start Year
1989
Number of shared co-authors
1
Torsten Haferlach
Taussig Cancer Institute, Cleveland Clinic
Career Start Year
1983
Number of shared co-authors
2
Robin Fo??
Sapienza University.
Career Start Year
1968
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Siraj M Ali
Foundation Medicine
Co-authored papers
4
Jeffrey S Ross
Foundation Medicine
Co-authored papers
4
Vincent A Miller
Injury Prevention Research Center, University of North Carolina
Co-authored papers
4
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Co-authored papers
2
Shashikant Kulkarni
Centene Center for Health Transformation, Centene Corporation
Co-authored papers
2
Dmitriy Sonkin
National Cancer Institute
Co-authored papers
2
Cristiane M Ida
Mayo Clinic Foundation
Co-authored papers
2
Padma S Rajagopal
National Cancer Institute, National Institutes of Health
Co-authored papers
2
Christopher S Carlson
University of Washington
Co-authored papers
2
Simon Kreutzfeldt
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Co-authored papers
2
Shruti Rao
Innovation Center for Biomedical Informatics, Georgetown University Medical Center
Co-authored papers
2
Kayoko Tao
National Cancer Center Hospital
Co-authored papers
2
Yassmine Akkari
Association for Molecular Pathology
Co-authored papers
2
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Co-authored papers
2
Kilannin Krysiak
Washington University School of Medicine
Co-authored papers
2
Rashmi Kanagal-Shamanna
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
Somak Roy
University of Cincinnati College of Medicine
Co-authored papers
2
Deborah I Ritter
Baylor College of Medicine
Co-authored papers
2
David Tamborero
Universitat Pompeu Fabra
Co-authored papers
2
Jeremy L Warner
Vanderbilt University Medical Center
Co-authored papers
2
Michael Y Tolstorukov
Dana-Farber Cancer Institute
Co-authored papers
2
Malachi Griffith
Washington University
Co-authored papers
2
Arpad M Danos
McDonnell Genome Institute, Washington University in St Louis School of Medicine
Co-authored papers
2
Harry Lesmana
Genomic Medicine Institute, Cleveland Clinic Lerner Research Institute
Co-authored papers
2
Obi L Griffith
Washington University
Co-authored papers
2
Damian T Rieke
German Cancer Consortium and German Cancer Research Center
Co-authored papers
2
Xinjie Xu
Mayo Clinic
Co-authored papers
2
Debyani Chakravarty
Memorial Sloan Kettering Cancer Center
Co-authored papers
2
Beth A Pitel
Mayo Clinic
Co-authored papers
2
Lisa Barrow-Laing
Indiana University School of Medicine
Co-authored papers
2
1 - 30